Journal article
Tumor lysis syndrome and malignant melanoma
Medical oncology (Northwood, London, England), Vol.30(3), pp.364-364
2013
DOI: 10.1007/s12032-012-0364-z
PMID: 23673985
Abstract
Tumor lysis syndrome (TLS) is an oncological emergency that results from massive cytolysis of malignant cells with a sudden release of their contents into the systemic circulation. TLS was rarely described in patients with malignant melanoma. In this article, we describe two patients with malignant melanoma who developed this syndrome. In one of them, the syndrome occurred spontaneously, and this is the second description of spontaneous tumor lysis in a patient with melanoma. We reviewed the previous patients with melanoma-induced TLS and discussed the manifestations and the pathophysiology of the syndrome in our patients.
Details
- Title: Subtitle
- Tumor lysis syndrome and malignant melanoma
- Creators
- Meir Mouallem - Tel Aviv UniversityNoa Zemer-Wassercug - Tel Aviv UniversityEitan Kugler - Tel Aviv UniversityNadav Sahar - Tel Aviv UniversityRonnie Shapira-Frommer - Tel Aviv UniversityGinette Schiby - Tel Aviv University
- Resource Type
- Journal article
- Publication Details
- Medical oncology (Northwood, London, England), Vol.30(3), pp.364-364
- Publisher
- Springer US
- DOI
- 10.1007/s12032-012-0364-z
- PMID
- 23673985
- ISSN
- 1357-0560
- eISSN
- 1559-131X
- Language
- English
- Date published
- 2013
- Academic Unit
- Gastroenterology and Hepatology; Internal Medicine
- Record Identifier
- 9984359767302771
Metrics
17 Record Views